| 注册
首页|期刊导航|动物医学进展|牛支原体O256蛋白的原核表达及其免疫原性研究

牛支原体O256蛋白的原核表达及其免疫原性研究

余小娇 李芮芮 李祥慧 梁佳音 盛金良 陈创夫 马忠臣 王勇

动物医学进展2026,Vol.47Issue(8):15-20,6.
✕
动物医学进展2026,Vol.47Issue(8):15-20,6.

牛支原体O256蛋白的原核表达及其免疫原性研究

Expression of M.bovis O256 Protein and Evaluation of Its Immune Efficacy

余小娇 1李芮芮 1李祥慧 2梁佳音 1盛金良 1陈创夫 1马忠臣 1王勇1

作者信息

  • 1. 石河子大学动物科技学院,新疆石河子 832003||绵羊健康养殖与人兽共患病防控协同创新中心,新疆石河子 832003||动物健康养殖国际联合研究中心,新疆石河子 832003
  • 2. 天康生物制药有限公司,新疆乌鲁木齐 832003
  • 折叠

摘要

Abstract

Aimed to evaluate the immunogenicity of the recombinant protein O256 from Mycoplasma bovis,a prokaryotic expression plasmid carrying the O256 gene was successfully constructed and the recombinant protein was expressed.Mice were subcutaneously immunized with the protein to assess immune effects.Ser-um levels of IgG,IgG1,and IgG2a were measured by indirect ELISA using blood samples collected from the tail vein every 7 days.IFN-γ secretion was detected by ELISpot.The results showed that serum levels of IgG,IgG1,and IgG2a in the O256 immunized group were significantly higher than those in the PBS control group,indicating the induction of a humoral immune response.The IgG2a/IgG1 ratio indicated a bias to-ward a Th2-type immune response.Additionally,the ELISpot assay revealed that IFN-γ expression in splenic lymphocytes of the O256 group was significantly increased compared with the PBS group(P<0.005),demonstrating the activation of a cellular immune response.In conclusion,the O256 recombinant protein of Mycoplasma bovis demonstrates strong immunogenicity,identifying it as a promising candidate antigen for the development of a vaccine against bovine mycoplasmosis.

关键词

牛支原体/O256重组蛋白/抗体/干扰素

Key words

M.bovis/O256 recombinant protein/Antibody/Interferon

分类

农业科技

引用本文复制引用

余小娇,李芮芮,李祥慧,梁佳音,盛金良,陈创夫,马忠臣,王勇..牛支原体O256蛋白的原核表达及其免疫原性研究[J].动物医学进展,2026,47(8):15-20,6.

基金项目

石河子大学高层次人才科研启动项目(RCZK202456) (RCZK202456)

兵团重点研发计划项目(2024AB034-02) (2024AB034-02)

新疆维吾尔自治区"天池英才(青年博士)"计划项目(CZ004336) (青年博士)

动物医学进展

1007-5038

访问量0
|
下载量0
段落导航相关论文